Dong-A ST and ST Pharm Both Grow in Q3, Sales and Operating Profit Rise Together
Predicted impact: Low
Routine Q3 growth announcement; same results already covered in recent preliminary earnings.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.